Materiality pending
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Summary: - Apyx Medical reported a quarterly loss of $0.22 per share. - Revenue for the quarter ended March 2024 was $10.24 million. - Estimate revisions trend for Apyx is unfavorable, with a Zacks Rank #4 (Sell). - Industry rank for Medical-Products is in the top 40% of Zacks industries. Price Impact Rating: Bearish Impact Horizon Rating: Short-term Type: Earnings
- Summary:
- Apyx Medical reported a quarterly loss of $0.22 per share.
- Revenue for the quarter ended March 2024 was $10.24 million.
- Estimate revisions trend for Apyx is unfavorable, with a Zacks Rank #4 (Sell).
- Industry rank for Medical-Products is in the top 40% of Zacks industries.
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.